Proteomic analysis of cerebrospinal fluid before and after intrathecal injection of steroid into patients with postherpetic pain

Proteomics

Volumn 12, Issue 19-20, 2012, Pages 3105-3112

  Lu, Jingshan ^a   Katano, Tayo ^a   Nishimura, Wataru ^b   Fujiwara, Shunsuke ^b   Miyazaki, Shinichiro ^b   Okasaki, Issay ^c   Aritake, Kosuke ^c   Urade, Yoshihiro ^c   Minami, Toshiaki ^b   Ito, Seiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

2D DIGE; Biomedicine; CSF proteomics; ELISA; Lipocalin type prostaglandin D synthase; Postherpetic pain

Indexed keywords

LIDOCAINE; LIPOCALIN; METHYLPREDNISOLONE; PROSTAGLANDIN D SYNTHASE;

ACCURACY; AGED; ANALYZER; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; OUTPATIENT; PAIN ASSESSMENT; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STEROID THERAPY; TREATMENT OUTCOME; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANESTHETICS, LOCAL; ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; CEREBROSPINAL FLUID PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; INJECTIONS, SPINAL; LIDOCAINE; MALE; METHYLPREDNISOLONE; MIDDLE AGED; NEURALGIA, POSTHERPETIC; PROTEOME; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84867836577     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200125     Document Type: Article

References (27)

1. Dworkin, R. H., Portenoy, R. K., Pain and its persistence in herpes zoster. Pain 1996, 67, 241-251.
2. Schmader, K. E., Dworkin, R. H., Natural history and treatment of herpes zoster. J. Pain 2008, 9, S3-S9.
3. Jung, B. F., Johnson, R. W., Griffin, D. R., Dworkin, R. H., Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004, 62, 1545-1551.
4. Opstelten, W., van Wijck, A. J., Stolker, R. J., Interventions to prevent postherpetic neuralgia: cutaneous and percutaneous techniques. Pain 2004, 107, 202-206.
5. Kumar, V., Krone, K., Mathieu, A., Neuraxial and sympathetic blocks in herpes zoster and postherpetic neuralgia: an appraisal of current evidence. Reg. Anesth. Pain Med. 2004, 29, 454-461.
6. van Wijck, A. J., Opstelten, W., Moons, K. G., van Essen, G. A. et al., The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trial. Lancet 2006, 367, 219-224.
7. Ji, G., Niu, J., Shi, Y., Hou, L. et al., The effectiveness of repetitive paravertebral injections with local anesthetics and steroids for the prevention of postherpetic neuralgia in patients with acute herpes zoster. Anesth. Analg. 2009, 109, 1651-1655.
8. Khwaja, F. W., Nolen, J. D., Mendrinos, S. E., Lewis, M. M. et al., Proteomic analysis of cerebrospinal fluid discriminates malignant and nonmalignant disease of the central nervous system and identifies specific protein markers. Proteomics 2006, 6, 6277-6287.
9. Steinacker, P., Rist, W., Swiatek-de-Lange, M., Lehnert, S. et al., Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldt-Jakob disease. Proteomics 2010, 10, 81-89.
10. 2 synthase as a putative biomarker for pediatric medulloblastoma: a pediatric brain tumor consortium study. Proteomics 2011, 11, 935-943.
11. Kotani, N., Kushikata, T., Hashimoto, H., Kimura, F. et al., Intrathecal methylprednisolone for intractable postherpetic neuralgia. N. Engl. J. Med. 2000, 343, 1514-1519.
12. Mortz, E., Krogh, T. N., Vorum, H., Görg, A., Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis. Proteomics 2001, 1, 1359-1363.
13. Gharahdaghi, F., Weinberg, C. R., Meagher, D. A., Imai, B. S. et al., Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis 1999, 20, 601-605.
14. Katano, T., Mabuchi, T., Okuda-Ashitaka, E., Inagaki, N. et al., Proteomic identification of a novel isoform of collapsin response mediator protein-2 in spinal nerves peripheral to dorsal root ganglia. Proteomics 2006, 6, 6085-6094.
15. Lu, J., Katano, T., Okuda-Ashitaka, E., Oishi, Y. et al., Involvement of S-nitrosylation of actin in inhibition of neurotransmitter release by nitric oxide. Mol. Pain 2009, 5, 58.
16. Oda, H., Shiina, Y., Seiki, K., Sato, N. et al., Development and evaluation of a practical ELISA for human urinary lipocalin-type prostaglandin D synthase. Clin. Chem. 2002, 48, 1445-1453.
17. Hoffmann, A., Conradt, H. S., Gross, G., Nimtz, M. et al., Purification and chemical characterization of β-trace protein from human cerebrospinal fluid: its identification as prostaglandin D synthase. J. Neurochem. 1993, 61, 451-456.
18. Smith, W. L., Urade, Y., Jakobsson, P. J., Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis. Chem. Rev. 2011, 111, 5821-5865.
19. Eguchi, N., Minami, T., Shirafuji, N., Kanaoka, Y. et al., Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. Proc. Natl. Acad. Sci. USA 1999, 96, 726-730.
20. Urade, Y., Kitahama, K., Ohishi, H., Kaneko, T. et al., Dominant expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus and oligodendrocytes of the adult rat brain. Proc. Natl. Acad. Sci. USA 1993, 90, 9070-9074.
21. Harrington, M. G., Aebersold, R., Martin, B. M., Merril, C. R. et al., Identification of a brain-specific human cerebrospinal fluid glycoprotein, β-trace protein. Appl. Theor. Electrophor. 1993, 3, 229-234.
22. Tunami, H., Nau, R., Felgenhauer, K., β-Trace protein in cerebrospinal fluid: a blood-CSF barrier-related evaluation in neurological diseases. Ann. Neurol. 1998, 44, 882-889.
23. Dorta-Contreras, A. J., Reiber, H., Aguero-Valdes, E., Interian-Morales, M. T. et al., Beta-trace protein in the cerebrospinal fluid and serum in meningoencephalitis. Rev. Neurol. 1998, 26, 386-388.
24. Melegos, D. N., Freedmann, M. S., Diamandis, E. P., Prostaglandin D synthase concentration in cerebrospinal fluid and serum of patients with neurological disorders. Prostaglandins 1997, 54, 463-474.
25. Mase, M., Yamada, K., Shimazu, N., Seiki K. et al., Lipocalin-type prostaglandin D synthase (beta-trace) in cerebrospinal fluid: a useful marker for the diagnosis of normal pressure hydrocephalus. Neurosci. Res. 2003, 47, 455-459.
26. Gebicke-Haerter, P. J., Schobert, A., Dieter, P., Honegger, P. et al., Regulation and glucocorticoid-independent induction of lipocortin I in cultured astrocytes. J. Neurochem. 1991, 57, 175-183.
27. García-Fernández, L. F., Iñiguez, M. A., Eguchi, N., Fresno, M. et al., Dexamethasone induces lipocalin-type prostaglandin D synthase gene expression in mouse neuronal cells. J. Neurochem. 2000, 75, 460-470.